10 Best Small-Cap Stocks Ready To Explode
On October 7, Chuck Royce, founder and Senior Advisor, and Francis Gannon, Co-Chief Investment Officer and Managing Director of Royce Investment, discussed the outperformance of small-cap stocks.
Neumora Therapeutics Inc. (NMRA)
Market is closed
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.98 | 3,357 | Large Shareholder, Director | 4,131,207 | 2023-11-14 | Filing | |
| $11.75 | 31,653 | Large Shareholder, Director | 4,127,850 | 2023-11-13 | Filing | |
| $11.98 | 3,357 | Large Shareholder | 4,131,207 | 2023-11-14 | Filing | |
| $11.75 | 31,653 | Large Shareholder | 4,127,850 | 2023-11-13 | Filing | |
| $11.75 | 5,431 | Large Shareholder, Director | 4,096,197 | 2023-11-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.03 | 14,049 | 20,100 | 2024-10-18 | Filing | ||
| $17.01 | 7,739 | 20,100 | 2024-10-17 | Filing | ||
| $15.09 | 8,260 | 314,706 | 2024-10-10 | Filing | ||
| $15.01 | 5,563 | 322,966 | 2024-10-09 | Filing | ||
| $12.09 | 10,676 | 328,529 | 2024-09-18 | Filing |
News See All
Neumora Therapeutics, Inc. Common Stock (NASDAQ:NMRA) Q3 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session.
Wall Street Analysts See Upside Potential for 5 Stocks with Rising Price Targets
In this article, we will discuss the 10 stocks whose price targets were recently raised by analysts.
Hedge Fund and Insider Trading News: Michael Platt, Bridgewater Associates, Millennium Management, Sosin Partners, Lynx Asset Management, Morgan Creek Capital Management, Berkshire Hills Bancorp Inc (BHLB), Enphase Energy, Inc. (ENPH), and More
Michael Platt is a British billionaire hedge fund manager and the co-founder and CEO of BlueCrest Capital Management.
Billionaire Hedge Funds
